SCS Research Study
- Conditions
- Trunk PainLimb Pain
- Interventions
- Device: Spinal Cord Stimulation
- Registration Number
- NCT03763708
- Lead Sponsor
- MedtronicNeuro
- Brief Summary
To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.
- Detailed Description
This post market study will measure the following:
* Numeric Pain Rating Scale
* Satisfaction and Stimulation Assessment
* Stimulation feedback
* Stimulation parameters
* Anatomical locations of active contacts
* Stimulation thresholds
* Location of paresthesia
* Oswestry Disability Index
* European Quality of Life 5-Dimensions
* To characterize non-invasive health monitoring data
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 100
- 22 years of age or older
- Implanted with a Medtronic rechargeable neurostimulation system, for a labeled indication, for at least 1 month and expected longevity of neurostimulator is at least 5 months
- Willing and able to provide signed and dated informed consent
- Capable of comprehending and consenting in English
- Willing and able to comply with all study procedures, including diary completion, and visits
- Able to differentiate between pain associated with the indication for SCS implant and other types of pain
- Implanted with neurostimulation system for an off-label indication
- Currently enrolled or planning to enroll in an interventional clinical study that could potentially confound the study results
- If female, pregnant or is of child-bearing potential and unwilling to use a medically acceptable form of birth control during the study
- Has untreated major psychiatric comorbidity
- Has a non-rechargeable neurostimulator where the battery longevity is not able to be estimated with the battery longevity calculator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Spinal Cord Stimulation Spinal Cord Stimulation Each subject will be programmed to different settings.
- Primary Outcome Measures
Name Time Method Numeric Pain Rating Scale (NPRS) - Cohort 1 Up to 5 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 2 Up to 2 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 3 Up to 3 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 4 Up to 5 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale - Cohort 5 Up to 5 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 6 Up to 7 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 7 Up to 8 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale (NPRS) - Cohort 8 Up to 0.5 months To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
Numeric Pain Rating Scale at Enrollment (NPRS) - Cohort 9 Up to 1 month To characterize the effect of different programmed settings on pain relief. The NPRS will be recorded once or daily over a period of time, where the subjects will rate their pain on a 11-point numeric rating scale of 0 to 10, with 0 representing 'No Pain' and 10 representing 'Worst pain imaginable'. The average overall NPRS pain score prior to the scheduled visit will be used for analysis.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
Center for Pain and Supportive Care
🇺🇸Phoenix, Arizona, United States
Goodman Campbell Brain and Spine
🇺🇸Carmel, Indiana, United States
Drez One
🇺🇸Somerset, Kentucky, United States
Regional Brain and Spine
🇺🇸Cape Girardeau, Missouri, United States
Center for Interventional Pain and Spine
🇺🇸Lancaster, Pennsylvania, United States
Carolinas Research Institute
🇺🇸Huntersville, North Carolina, United States
Pain Diagnostics and Interventional Care
🇺🇸Sewickley, Pennsylvania, United States
Northwest Pain Care
🇺🇸Spokane, Washington, United States
Twin Cities Pain Clinic
🇺🇸Edina, Minnesota, United States